Makes Taser devices and body cameras, and sells the cloud software police use for evidence.
$390.29close as of 2026-10-16
-40.2% over 1Y · 56.9 points behind the S&P 500
AXONS&P 500 (SPY), rebased to AXON's first close
“Can Axon turn expanding software subscriptions and contracted bookings into stronger cash flow as new product spending continues?”
Editorial note · updated 2026-10-08
The TenQ Radar
Axon in 36 checks
Axon on the TenQ Radar: value, growth, quality, health, shareholder returns and trend. The fuller the shape, the stronger the company. Behind each axis are six pass-or-fail checks from its filings, spelled out in the chapters below. Point at an axis to see them.
A mixed picture, with strengths and real weaknesses: 10 of 36 checks passed.
The Axon story
What drives Axon, what its price assumes and what could change the story, written from its own filings.
Subscriptions deepen relationships. In the quarter to June 2026, annual recurring revenue grew 39% to $1.6 billion and net revenue retention reached 126%.
Contracts extend demand. Future contracted bookings reached $15.1 billion in the quarter to June 2026, including two nine-figure agreements with major U.S. cities and Axon's largest individual TASER order.
Cash conversion trails growth. Revenue rose 35% to $904 million in the quarter to June 2026, but free cash outflow was $1 million despite $242 million of Adjusted EBITDA.
Q2 '26 · quarter to 30 June 2026 · reported 5 August 2026 · Earnings release ↗
Revenue$904M+35%vs 2025+12%vs Q1
Earnings$29M-19%vs 2025-83%vs Q1
What the release says
Highlights
Axon reported Q2 2026 revenue of $904 million, up 35% year over year, with annual recurring revenue growing 39% to $1.6 billion and net revenue retention reaching 126%.
Platform Solutions revenue grew 123% year over year to $150 million, and Dedrone revenue surpassed $100 million, reflecting strong adoption of new product lines and counter-drone technology.
Future contracted bookings increased 41% year over year to $15.1 billion, including two nine-figure agreements with major U.S. cities and the largest individual TASER order in company history.
The company launched Axon Body Mini for enterprise customers and highlighted measurable operational improvements in customer deployments, such as reduced response times and crime rates in Brookhaven Police Department.
What management expects
The company expects full-year 2026 revenue growth in a range of 32% to 34%, up from the previous outlook of 30% to 32%.
Axon continues to expect a full-year 2026 Adjusted EBITDA margin of approximately 25.5%.
Full-year 2026 stock-based compensation expense is expected to be approximately $590 million to $620 million, and 2026 capital expenditures are expected to be in the range of $160 million to $190 million.
Key risks
Axon substantially depends on continued acceptance of its products and services by law enforcement agencies worldwide, and any reduction in demand from this customer base could materially adversely affect its business, operating results, and financial condition.
A significant portion of revenue is derived from sales of Conducted Energy Devices (CEDs), and if these products do not continue to be widely accepted, Axon's growth prospects and financial condition could be diminished.
The company faces risks from rapid technological change and new competing products, which could render existing products obsolete or less competitive.
Security breaches of Axon's products, services, or those of third-party providers could result in unauthorized access to customer data, undermining confidence in its network and leading to legal and financial exposure.
AI summary of the company's filings, every number checked against them · 8 October 2026 · Sources: earnings release, 10-K, 10-Q
Earnings alerts
An email when Axon reports, with its results and highlights. Free with a watchlist account.
I
Value
●●●●●●0/6
Expensive against its own history and its sector: the price asks a lot of the business.
161.3xown 8-year median 101.8x
9.8xown 10-year median 8.1x
0.4%cash earned per $ of price
246.1xwhole-business multiple
Valuation history
Is AXON's P/E, P/S or P/B high or low against its own past?
Year
P/E
P/S
P/B
2016
70.0348
4.516
8.0284
2017
249.5155
3.779
7.7592
2018
101.7975
7.0774
6.3617
2019
4,138
6.8744
6.7146
2022
63.4695
7.8555
7.3391
2023
88.8706
10.0096
9.6684
2024
76.587
13.8658
12.4055
2025
437.6502
19.6276
16.8244
2026
161.3071
9.8494
8.6286
◌ 2026 = at the latest close (2026-10-16), over the trailing twelve months; earlier years are annual averages · the last point is at the latest close (2026-10-16); earlier quarters use that quarter's average price over the trailing twelve months to it
→At 161.3x earnings, the market is paying +58% more than AXON's own 8-year median of 101.8x. Expectations are elevated, so more has to go right to justify the price.
What this measures
What the market has paid for each dollar of earnings, sales or book value, every year, with today's multiple as the last point and the median drawn across.
What good looks like. There is no good level. What matters is the distance from the company's own history, and whether the business has changed enough to justify it.
If it rises or falls. A multiple above its own median means the market expects more than it used to, so more has to go right. Below the median means the opposite, and the question is whether the pessimism is deserved. A multiple can also fall because earnings rose, which is the good way.
Earnings yield
Does AXON's earnings yield beat a 10-year Treasury?
Period
Earnings yield
10-year Treasury
2016
0.0143
0.0183
2017
0.004
0.0233
2018
0.0098
0.0289
2019
0.0002
0.0208
2022
0.0158
0.03
2023
0.0113
0.0397
2024
0.0131
0.0424
2025
0.0023
0.0425
2026
0.0062
0.051
◌ 2026 = at the latest close (2026-10-16), over the trailing twelve months; earlier years are annual averages · the last point is at the latest close (2026-10-16); earlier quarters use that quarter's average price over the trailing twelve months to it · the Treasury line is the average 10-year yield over the same year or quarter, and today's yield at the last point
→At today's price, AXON earns 0.6% of its share price in profit a year, less than the 5.1% a 10-year Treasury pays.
What this measures
Earnings yield is profit per share divided by the share price: 1 ÷ P/E. It is the profit you buy with each dollar of share price. The 10-year US Treasury yield is what the government pays, with no risk to the payment, for lending to it for ten years.
What good looks like. An earnings yield above the Treasury yield: each dollar in the shares buys more profit than the same dollar earns in a government bond.
If it rises or falls. It falls when the share price rises faster than profit, and the bar rises when interest rates do: a higher Treasury yield makes the same shares harder to justify. A company whose profit is growing fast can sit below the line for years, which is what the price is betting on.
Free cash flow yield
What is AXON's free cash flow yield at today's price?
Period
FCF yield
2016
0.0134
2017
0.0062
2018
0.0177
2019
0.0136
2020
-0.0062
2021
0.0069
2022
0.0193
2023
0.0083
2024
0.0114
2025
0.0014
2026
0.0042
◌ 2026 = at the latest close (2026-10-16), over the trailing twelve months; earlier years are annual averages · the last point is at the latest close (2026-10-16); earlier quarters use that quarter's average price over the trailing twelve months to it
→Every dollar of market value currently buys 0.4% of annual free cash flow, less than its 10-year median of 1.1% - you are paying up for the same cash.
What this measures
Free cash flow divided by market value: the cash the business generates for every dollar you pay for it. The inverse of a price-to-cash multiple.
What good looks like. A yield at or above the company's own history, and one that compares well with what cash is worth elsewhere.
If it rises or falls. The yield rises when cash grows or the price falls, so a high yield is either a bargain or a warning about the cash continuing. Read it beside the cash conversion chart, which shows whether the cash is holding up.
Enterprise value
What is AXON's EV/EBITDA: the price of the whole business, debt included?
Period
EV / EBITDA
2016
31.6091
2022
78.0788
2023
85.4679
2024
268.9487
2025
2,592
2026
246.0744
◌ 2026 = at the latest close (2026-10-16), over the trailing twelve months; earlier years are annual averages · the last point is at the latest close (2026-10-16); earlier quarters use that quarter's average price over the trailing twelve months to it
→Buying AXON outright - equity plus debt, less the cash - costs 246.1x its EBITDA, above the 14.0x a broad market median sits at. Its own history runs at 85.5x, so the whole business is dearer than usual.
What this measures
Enterprise value over EBITDA. Enterprise value is the market value of the equity plus debt, less cash and short-term investments - what it would cost to buy the whole company outright. EBITDA is operating profit before depreciation and amortisation.
What good looks like. A multiple below what similar businesses change hands at, and one that has not run far above the company's own past.
If it rises or falls. It rises when the price rises or profit falls, and debt moves it too: two companies on the same price-to-earnings can sit far apart here if one is carrying borrowings the other is not.
Value asks what you pay for each dollar of earnings, sales or cash the business produces. A high multiple isn't automatically bad - fast growers earn theirs - but a price far above the company's own history means the market expects a lot to go right. We compare each multiple to the company's own past and to its sector, never to a universal rule.
not profitable: no free cash flow or earnings for the price to rest on
II
Growth
●●●●●●4/6
Growing, with caveats: revenue +34.6% over the last year.
+34.6%vs the year before
+32.8%compound annual
-38.9%net income growth
-5.3%compound annual
Revenue history
Is AXON's revenue growing?
◌ dashed quarter = Q4 derived from the annual filing minus Q1, Q2 and Q3 (the SEC never receives a Q4 report)
Period
Revenue ($)
Q3 2011
24.4M
Q1 2012
25.6M
Q2 2012
28.2M
Q3 2012
28.8M
Q4 2012
32.1M
Q1 2013
30.4M
Q2 2013
32.2M
Q3 2013
35.2M
Q4 2013
40.0M
Q1 2014
36.2M
Q2 2014
37.2M
Q3 2014
44.3M
Q4 2014
46.8M
Q1 2015
44.8M
Q2 2015
46.7M
Q3 2015
50.4M
Q4 2015
56.0M
Q1 2016
55.5M
Q2 2016
58.8M
Q3 2016
71.9M
Q4 2016
82.1M
Q1 2017
79.2M
Q2 2017
79.6M
Q3 2017
90.3M
Q4 2017
94.7M
Q1 2018
101.2M
Q2 2018
99.2M
Q3 2018
104.8M
Q4 2018
114.8M
Q1 2019
115.8M
Q2 2019
112.4M
Q3 2019
130.8M
Q4 2019
171.9M
Q1 2020
147.2M
Q2 2020
141.3M
Q3 2020
166.4M
Q4 2020
226.1M
Q1 2021
195.0M
Q2 2021
218.8M
Q3 2021
232.0M
Q4 2021
219.8M
Q1 2022
256.4M
Q2 2022
285.6M
Q3 2022
311.8M
Q4 2022
333.4M
Q1 2023
344.3M
Q2 2023
372.7M
Q3 2023
413.3M
Q4 2023
430.4M
Q1 2024
459.9M
Q2 2024
503.2M
Q3 2024
544.3M
Q4 2024
575.1M
Q1 2025
603.6M
Q2 2025
668.5M
Q3 2025
710.6M
Q4 2025
796.7M
Q1 2026
807.3M
Q2 2026
904.4M
2011
90.0M
2012
114.8M
2013
137.8M
2014
164.5M
2015
197.9M
2016
268.2M
2017
343.8M
2018
420.1M
2019
530.9M
2020
681.0M
2021
865.6M
2022
1.19B
2023
1.56B
2024
2.08B
2025
2.78B
→Revenue reached $2.8B in 2025, compounding +33% a year since 2022 and the pace is picking up. The trailing twelve months are already running at $3.2B, ahead of the last full year.
What this measures
The money customers paid, before any costs are taken out. Each bar is one quarter or, on the annual view, a full financial year; the last annual bar may be the trailing twelve months, which the footnote marks.
What good looks like. Growth that repeats, rather than one strong year carrying the chart, and a trailing twelve months keeping pace with the last full year.
If it rises or falls. Revenue is the hardest line to flatter, so a rise is the most trustworthy kind of growth. A fall puts pressure on every margin below it, because costs rarely come down as quickly as sales do.
Revenue by regionInsight
Where does Axon's revenue come from?
dashed quarter = Q4 derived from the annual filing minus Q1, Q2 and Q3 (the SEC never receives a Q4 report)
→United States is Axon's larger region at $742M, 82% of $904M in 2026Q2, against $162M for International.
Source: SEC filings - segment disclosures (XBRL notes) · as at 2026-06-30
Profit history
Is AXON's net profit growing?
◌ dashed quarter = Q4 derived from the annual filing minus Q1, Q2 and Q3 (the SEC never receives a Q4 report)
Period
Net income ($)
Q3 2011
1.1M
Q4 2011
-5.9M
Q1 2012
3.8M
Q2 2012
3.4M
Q3 2012
3.7M
Q4 2012
3.8M
Q1 2013
3.3M
Q2 2013
4.5M
Q3 2013
5.1M
Q4 2013
5.4M
Q1 2014
3.4M
Q2 2014
3.9M
Q3 2014
7.6M
Q4 2014
5.1M
Q1 2015
7.2M
Q2 2015
6.1M
Q3 2015
1.5M
Q4 2015
5.1M
Q1 2016
3.5M
Q2 2016
3.6M
Q3 2016
3.8M
Q4 2016
6.3M
Q1 2017
4.6M
Q2 2017
2.3M
Q3 2017
422,000
Q4 2017
5.2M
Q1 2018
12.9M
Q2 2018
8.5M
Q3 2018
5.7M
Q4 2018
2.1M
Q1 2019
6.4M
Q2 2019
738,000
Q3 2019
6.1M
Q4 2019
-12.4M
Q1 2020
4.1M
Q2 2020
-30.8M
Q3 2020
-873,000
Q4 2020
25.8M
Q1 2021
-47.9M
Q2 2021
-47.1M
Q3 2021
48.5M
Q4 2021
-13.5M
Q1 2022
54.9M
Q2 2022
51.0M
Q3 2022
12.1M
Q4 2022
29.0M
Q1 2023
45.9M
Q2 2023
11.5M
Q3 2023
61.3M
Q4 2023
57.1M
Q1 2024
133.4M
Q2 2024
41.5M
Q3 2024
67.0M
Q4 2024
135.2M
Q1 2025
88.0M
Q2 2025
36.1M
Q3 2025
-2.2M
Q4 2025
2.7M
Q1 2026
169.3M
Q2 2026
29.4M
2011
-7.0M
2012
14.7M
2013
18.2M
2014
19.9M
2015
19.9M
2016
17.3M
2017
5.2M
2018
29.2M
2019
882,000
2020
-1.7M
2021
-60.0M
2022
146.9M
2023
175.8M
2024
377.0M
2025
124.7M
→Net income was $125M in 2025, compounding -5% a year over three years. Earnings per share moved -39% over the last twelve months. Trailing twelve-month profit stands at $199M. $226M of that is the revaluation of investment stakes, not operations - operating income over the same twelve months was $24M.
What this measures
What is left after every cost, including tax and interest. The bottom line of the income statement.
What good looks like. Profit growing at least as fast as revenue, which means the business is keeping more of each sale as it gets bigger.
If it rises or falls. Profit can move for reasons revenue cannot explain - a one-off charge, a tax change, a write-down - so a single sharp year is worth checking against the margin chart before reading it as a trend.
Growth rate
How fast are AXON's revenue and earnings growing?
Shown separately because they would flatten the axis: 2018 earnings +461% · 2020 earnings -295% - rebounds off a collapsed prior year.
Year
Revenue growth
Earnings growth
2,012
0.2746
-
2,013
0.2011
0.2379
2,014
0.1937
0.0918
2,015
0.2028
0.0008
2,016
0.3555
-0.1322
2,017
0.2817
-0.699
2,018
0.2218
-
2,019
0.2637
-0.9698
2,020
0.2828
-
2,021
0.2711
-
2,022
0.3714
-
2,023
0.3147
0.1964
2,024
0.3344
1.1449
2,025
0.3347
-0.6694
2026
0.346
-0.3892
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · on the quarterly views, growth is the trailing twelve months against the twelve before, or a quarter against the same quarter a year earlier
→Revenue grew 35% over the twelve months to 2026-06-30, against an average of +33% a year over 2021-2025. Earnings went the other way (fell 39%) even as sales grew, so margins compressed: costs rose faster than revenue.
What this measures
How much revenue and earnings changed against the year before - the trailing twelve months against the twelve before them at each quarter, or one point per fiscal year. It is the speed of the business, not its size.
What good looks like. The earnings line above the revenue line: profits growing faster than sales means each new dollar of sales arrives more profitably than the last.
If it rises or falls. A high growth rate off a small base is easy and gets harder every year, so slowing growth in a large business is normal rather than a warning. Earnings falling while revenue grows is the combination worth understanding: costs are rising faster than sales.
Per-share growth
Are AXON's revenue and free cash flow per share growing?
Year
Revenue per share ($)
Free cash flow per share ($)
2,011
1.5147
0.2593
2,012
2.097
0.4602
2,013
2.5453
0.5659
2,014
3.0188
0.6042
2,015
3.6219
0.7402
2,016
5.0106
0.3022
2,017
6.3787
0.1494
2,018
7.2523
0.9105
2,019
8.845
0.8287
2,020
11.0227
-0.5527
2,021
13.0779
1.1272
2,022
16.3667
2.4755
2,023
20.6836
1.7179
2,024
26.5094
4.1947
2,025
33.7445
0.9115
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→Revenue per share reached $33.74 in 2025, compounding +27% a year against +33% for AXON as a whole. Dilution absorbed about 5.5 points of that growth. The trailing twelve months are running at $39.08 a share. Free cash flow per share stands at $0.91.
What this measures
Revenue and free cash flow, each divided by the number of shares in issue and adjusted for splits so old and new years compare honestly. Both lines rising means each share owns more of the business's sales and cash.
What good looks like. Both lines rising, and revenue per share growing at least as fast as the company's total revenue, which the answer compares. Faster means buybacks are working for you; slower means new shares are absorbing part of the growth.
If it rises or falls. This is the line that actually reaches you. A company can grow revenue every year and still shrink your slice by issuing shares faster than it grows.
What does “Growth” actually mean?
Growth here is what the company has actually reported to the SEC - not a forecast. We look at the last year, the three-year pace, whether growth is speeding up or slowing down, and whether it's been consistent rather than one lucky year. Hatched bars are fourth quarters we derived from annual filings (companies file a full-year 10-K rather than a Q4 report).
A solidly profitable business, though not exceptional against its sector.
59.4%kept after direct costs
0.7%kept after running costs
6.1%profit on shareholders' money
0.4%against a 10% cost of capital
133%operating cash ÷ net income
Margins
What profit margin does AXON keep on each sale?
Year
Gross
Operating
Net
2,011
0.4946
-0.1213
-0.0782
2,012
0.5901
0.1963
0.1284
2,013
0.6228
0.2028
0.1324
2,014
0.6172
0.1976
0.1211
2,015
0.6501
0.1786
0.1007
2,016
0.6357
0.1187
0.0645
2,017
0.6024
0.0379
0.0151
2,018
0.6156
0.0591
0.0695
2,019
0.5788
-0.012
0.0017
2,020
0.6113
-0.0208
-0.0025
2,021
0.6304
-0.1885
-0.0693
2,022
0.6116
0.0783
0.1238
2,023
0.6122
0.1005
0.1126
2,024
0.5961
0.0281
0.181
2,025
0.5965
-0.0223
0.0448
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→Operating margin compressed 10 points to -2% since 2022. After everything, 4 cents of each sales dollar reaches net profit.
What this measures
What survives at three points on the way down the income statement: after the direct cost of the product, after the cost of running the company, and after everything.
What good looks like. Margins that hold or widen as the business grows. The level itself varies enormously by industry, so the shape over time tells you more than the number.
If it rises or falls. A widening margin means pricing power or costs under control. A compressing one means the opposite, and it compounds: on large revenue, two points of margin is a great deal of profit.
Earnings quality
Does AXON's operating cash flow keep up with its profit?
Year
Cash from operations
Net income
2,011
17.3M
-7.0M
2,012
26.5M
14.7M
2,013
32.4M
18.2M
2,014
35.4M
19.9M
2,015
46.4M
19.9M
2,016
21.1M
17.3M
2,017
18.5M
5.2M
2,018
63.9M
29.2M
2,019
65.7M
882,000
2,020
38.5M
-1.7M
2,021
124.5M
-60.0M
2,022
235.4M
146.9M
2,023
189.3M
175.8M
2,024
408.3M
377.0M
2,025
211.3M
124.7M
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→$226M of AXON's $199M trailing profit is the revaluation of investment stakes, not cash from customers - which is why operating cash flow, at $266M, sits so far below it. Strip the paper gains out and the business converts its profit to cash at -992%.
What this measures
Reported profit against the cash the business actually collected from operating. Profit is an accounting judgement; cash is not.
What good looks like. Cash at or above profit, year after year. Depreciation and other non-cash charges usually push cash above profit, so roughly 100% or more is healthy.
If it rises or falls. Cash falling behind profit for more than a year is the classic early warning: the sales are booked but the money has not arrived, and it shows up in receivables and inventory. For a lender the comparison behaves differently, because a growing loan book consumes cash.
Returns on capital
What return on equity and on capital does AXON earn?
Year
ROE
ROA
ROCE
2,011
-0.0704
-0.0671
-0.1225
2,012
0.1737
0.1268
0.2296
2,013
0.1865
0.123
0.2231
2,014
0.1678
0.1075
0.2119
2,015
0.1393
0.0867
0.1843
2,016
0.1124
0.0622
0.1592
2,017
0.0327
0.0154
0.0566
2,018
0.092
0.0406
0.0449
2,019
0.0017
0.001
-0.0098
2,020
-0.0023
-0.0012
-0.0126
2,021
-0.0592
-0.0356
-0.1285
2,022
0.1266
0.0515
0.0413
2,023
0.1218
0.0516
0.0592
2,024
0.1912
0.0843
0.0209
2,025
0.0448
0.0178
-0.0112
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→ROE of 6% sits well above ROCE of 0%. A meaningful share of the shareholder return is manufactured with leverage rather than operations.
What this measures
Two returns side by side: on shareholders' capital (ROE), and on all the capital in the business including debt (ROCE).
What good looks like. Both comfortably above roughly 10%, and close together. A wide gap means borrowing, not operations, is doing the work.
If it rises or falls. A high ROE built on debt looks like quality until the debt has to be refinanced. ROCE is the harder number to flatter, which is why both are shown.
Income waterfall
Where does AXON's revenue go, from sales to net profit?
Step
Amount ($)
Revenue, last 12m
3.22B
Gross profit
1.91B
Operating income
23.8M
Net income
199.3M
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→Of $3.2B over the twelve months to 2026-06-30 sales, $1.9B survives production costs, $24M survives running the company, and $199M - 6¢ of every dollar - reaches the bottom line.
What this measures
One year of revenue, with each major cost taken out in the order the income statement takes it, ending at net profit.
What good looks like. No single step swallowing a surprising share, and a bottom line that survives all of them.
If it rises or falls. The largest step is where the business really spends its money, and it is the one to watch year to year: a step that grows faster than revenue is what margin compression looks like before it reaches the margin chart.
Cash conversion
How much of each sale does AXON turn into free cash flow?
Period
FCF margin
2011
0.1712
2012
0.2195
2013
0.2223
2014
0.2001
2015
0.2044
2016
0.0603
2017
0.0234
2018
0.1255
2019
0.0937
2020
-0.0501
2021
0.0862
2022
0.1513
2023
0.0831
2024
0.1582
2025
0.027
→3 cents of every sales dollar became free cash in 2025, down 12 points since 2022.
What this measures
Free cash flow as a share of revenue: how much of each dollar of sales survives both costs and capital spending.
What good looks like. A steady or rising share. Asset-light businesses convert far more than manufacturers, so compare a company with itself.
If it rises or falls. Falling conversion while revenue grows means growth is being bought with capital spending or working capital, which is fine while it lasts and painful when it stops.
Spending intensity
How much of its revenue does AXON spend on capex, R&D and stock pay?
Year
Capex % of rev
R&D % of rev
Stock comp % of rev
2,011
0.0206
0.111
0.0337
2,012
0.0116
0.0709
0.0298
2,013
0.0129
0.0717
0.0315
2,014
0.0152
0.0905
0.0339
2,015
0.0303
0.1193
0.0367
2,016
0.0185
0.1141
0.0349
2,017
0.0303
0.1611
0.0454
2,018
0.0265
0.183
0.0521
2,019
0.03
0.1897
0.1479
2,020
0.1067
0.1809
0.1961
2,021
0.0576
0.2241
0.3504
2,022
0.047
0.197
0.0894
2,023
0.0382
0.1946
0.0842
2,024
0.0378
0.212
0.1837
2,025
0.049
0.2462
0.2282
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→The biggest claim on each sales dollar is research and development, at 25% of revenue (stock compensation 23%, capital spending 5%). That share has risen since 2022, so the cost of competing is climbing.
What this measures
Capital spending, research and development, and stock compensation, each as a share of revenue. The three ways a business pays to keep its position.
What good looks like. A share that is stable or falling while revenue grows, which means the cost of competing is not rising with the business.
If it rises or falls. Rising intensity means each new dollar of sales is getting more expensive to win. Falling intensity can mean efficiency, or it can mean under-investment that shows up years later.
Operating leverage
Does AXON's operating profit grow faster than its revenue?
Year
Revenue growth
Operating income growth
2,013
0.2011
0.2405
2,014
0.1937
0.1631
2,015
0.2028
0.0871
2,016
0.3555
-0.0986
2,017
0.2817
-0.5911
2,018
0.2218
0.9075
2,019
0.2637
-1.2574
2,023
0.3147
0.687
2,024
0.3344
-0.6268
2,025
0.3347
-2.0604
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · on the quarterly views, growth is the trailing twelve months against the twelve before, or a quarter against the same quarter a year earlier
→Operating profit outgrew revenue in only 2 of the last 5 years. Costs are growing roughly in step with the business, so scale isn't yet paying for itself.
What this measures
How often operating profit grew faster than revenue, year by year. Fixed costs mean profit should rise faster than sales once those costs are covered.
What good looks like. Profit outgrowing revenue in most years, and by a widening margin in the good ones.
If it rises or falls. Leverage cuts both ways: the same fixed costs that multiply profit on the way up multiply the damage when sales fall. A business with strong operating leverage is a better business and a more volatile one.
Return on capital employed
Is AXON's return on capital above what its capital costs?
Period
Return on capital employed
2011
-0.1225
2012
0.2296
2013
0.2231
2014
0.2119
2015
0.1843
2016
0.1592
2017
0.0566
2018
0.0449
2019
-0.0098
2020
-0.0126
2021
-0.1285
2022
0.0413
2023
0.0592
2024
0.0209
2025
-0.0112
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→AXON's return on capital is negative at -1.1% in 2025. The capital in the business is not yet earning anything back.
What this measures
The same return as the card above, but every filed year, against a 10% line that stands in for what capital costs.
What good looks like. Years above the line, and a trend that is flat or rising rather than drifting down towards it.
If it rises or falls. A business earning above its cost of capital creates value by growing; one earning below it destroys value by growing. The 10% line is a convention, not a law, so read the distance from it rather than the crossing.
What does “Quality” actually mean?
Quality asks whether the growth makes real money. Margins show how much of each sale survives costs; return on equity shows what shareholders earn on their capital; and the profit-to-cash comparison catches companies whose accounting profits never turn into actual cash.
Financially sound overall, with one or two things worth watching.
0.47xborrowed vs owned
2.1xnear-term bills coverage
0xearnings ÷ interest bill
$673Mcash plus short-term investments
Debt & cash
How much debt does AXON carry, and do its profits cover the interest?
Year
Total debt
Cash & investments
2,012
-
37.8M
2,013
-
51.4M
2,014
29,000
81.1M
2,015
81,000
109.8M
2,016
81,000
89.1M
2,017
-
82.0M
2,018
-
349.5M
2,019
-
350.8M
2,020
-
562.0M
2,021
-
370.8M
2,022
674.0M
935.5M
2,023
677.1M
1.24B
2,024
680.3M
788.1M
2,025
1.81B
1.71B
2,026
1.73B
673.4M
◌ each quarterly point is the balance sheet at that quarter end
→Debt of $1.7B sits against $673M of cash, or 0.5x shareholders' equity. Earnings cover interest only 0.2 times, which is thin.
What this measures
Total borrowings against cash on hand, with debt as a multiple of shareholders' equity, and how many times profit covers the interest bill.
What good looks like. Interest covered comfortably - roughly eight times or more - and debt that is not a large multiple of equity.
If it rises or falls. Debt is only a problem when it has to be repaid or refinanced in a bad year, so cover matters more than the amount. Rising debt with rising cover is a business borrowing to grow; rising debt with falling cover is the combination that ends badly.
Near-term liquidity
Do AXON's current assets cover the bills due within a year?
Period
Current ratio
2011
3.8855
2012
4.3654
2013
4.2141
2014
4.2111
2015
4.232
2016
2.2711
2017
1.9008
2018
3.3622
2019
3.1165
2020
3.8308
2021
2.651
2022
2.9956
2023
3.1432
2024
1.3693
2025
2.5256
◌ 2026 = the latest balance sheet (2026-06-30), not a fiscal year-end · each quarterly point is the balance sheet at that quarter end
→Near-term liquidity is comfortable: 2.1x of current assets for every dollar due within the year. That is thinner than in 2011.
What this measures
Current assets over current liabilities: what the company can turn into cash within a year against what it owes within a year.
What good looks like. Comfortably above 1.0, and not falling year after year. Below 1.0 means near-term bills exceed near-term resources, which is normal for some business models and a warning in others.
If it rises or falls. Inventory and receivables build it up; short-term borrowing and payables pull it down. A retailer that turns stock over quickly can run lower than a manufacturer and be perfectly sound.
Interest cover
How many times over can AXON's operating profit pay its interest bill?
Period
Interest cover (x)
2023
22.4232
2024
8.2474
2025
-0.6587
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→Operating profit does not cover the interest bill (0.2x).
What this measures
Operating profit divided by interest expense - how many times over the year's earnings could pay the year's interest.
What good looks like. High and steady. Five times is a common floor; comfortably above it means the debt is being carried, not merely serviced.
If it rises or falls. It falls when profit falls or when borrowing costs rise, and a company can look safe on the level while the direction is telling you otherwise.
Cash conversion
How much of AXON's revenue arrives as operating cash?
Period
Operating cash flow / revenue
2011
0.1918
2012
0.2311
2013
0.2353
2014
0.2154
2015
0.2347
2016
0.0788
2017
0.0537
2018
0.1521
2019
0.1237
2020
0.0565
2021
0.1438
2022
0.1983
2023
0.1213
2024
0.1961
2025
0.076
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→8.3% of every dollar AXON sold arrived as operating cash. Down from 19.2% in 2011.
What this measures
Operating cash flow as a share of revenue: of every dollar sold, how much reached the bank before capital spending.
What good looks like. A high share, holding up or improving. It is the clearest sign that reported profit is real.
If it rises or falls. It falls when customers take longer to pay or stock builds up, and it can stay high while profit falls - which is usually the more reassuring of the two.
Shareholders' equity
Is AXON's shareholder equity (book value) growing?
Period
Equity ($)
2012
87.3M
2013
108.3M
2014
129.1M
2015
157.0M
2016
150.9M
2017
167.4M
2018
467.3M
2019
543.5M
2020
976.3M
2021
1.05B
2022
1.27B
2023
1.62B
2024
2.33B
2025
3.24B
2026
3.67B
→The company's own capital grew from $1.6B in 2023 to $3.7B (+127%). The business is building book value rather than consuming it.
What this measures
What would be left for shareholders if every asset were sold at its book value and every debt repaid. Book value, in other words.
What good looks like. Equity growing as retained profits build up, unless the company is deliberately returning more than it earns.
If it rises or falls. Equity falls for two very different reasons: buybacks, which return money to you, and losses, which do not. The distinction is the whole story, and negative equity means liabilities now exceed assets, which makes debt-to-equity and return on equity meaningless rather than alarming.
What does “Health” actually mean?
Health asks one question: can the business survive a bad year? We check whether near-term bills are covered, whether debt is modest and shrinking, whether earnings comfortably pay the interest, and - for loss-makers - how many years of cash are left at the current burn rate.
AXON returns nothing to shareholders yet, and the share count keeps rising. Every dollar stays in the business.
+0.00%bought back, TTM, over market value
-at the current rate
$0.00dividends plus buybacks
$633Mlast 12m, dilutes the buybacks
+36.9%since 2011 (split-adjusted)
Capital returned vs stock comp
Do AXON's buybacks and dividends outweigh the stock it issues to staff?
Year
Buybacks
Dividends
Stock comp
2,011
32.5M
-
3.0M
2,012
20.0M
-
3.4M
2,013
25.0M
-
4.3M
2,014
22.4M
-
5.6M
2,015
7.6M
-
7.3M
2,016
33.7M
-
9.4M
2,017
-
-
15.6M
2,018
-
-
21.9M
→AXON returned no cash to shareholders in the latest filed year: everything is being retained or reinvested.
What this measures
Cash returned through buybacks and dividends, alongside the value of new shares issued to employees as compensation.
What good looks like. Returns comfortably larger than stock compensation, so the share count actually falls.
If it rises or falls. A company can announce billions in buybacks while issuing nearly as much stock to staff, and the two largely cancel. What reaches you is the net effect, which is why both bars are here rather than only the buyback.
Shareholder yield
What is AXON's shareholder yield from dividends and buybacks?
Year
Buyback yield
Dividend yield
2,016
0.0279
-
2,017
0
-
2,018
0
-
→AXON handed back 0.0% of its market value over the last twelve months, below the 2% this check asks for. All of it is the dividend; AXON is not buying back stock.
What this measures
Dividends and buybacks, each as a percentage of what the company was worth that year. The dollar chart says how much came back; this says how much came back for the price.
What good looks like. A total that clears a couple of percent and holds. Which half it comes from matters less than whether it is sustained.
If it rises or falls. A yield rises when the price falls as readily as when the payout grows, so read a jump beside the price chart before treating it as generosity.
Share count change (split-adjusted)
Is AXON's share count rising or falling?
Year
Share-count change
2,012
-0.0793
2,013
-0.0104
2,014
0.0064
2,015
0.0025
2,016
-0.0202
2,017
0.0068
2,018
0.0747
2,019
0.0362
2,020
0.0294
2,021
0.0714
2,022
0.0958
2,023
0.0403
2,024
0.0411
2,025
0.0485
→The share count grew 4.9% in 2025, averaging 4.3% a year over three years. Your slice of the company shrinks by that much each year unless earnings grow faster.
What this measures
The yearly change in the number of shares in issue, adjusted for splits so the years compare. A bar below zero is a falling share count, usually from buybacks; above zero, new shares were issued.
What good looks like. A flat or falling share count. Falling means each share you hold owns a little more of the business every year.
If it rises or falls. A rising count divides the same business among more owners, so your slice shrinks unless profits grow faster. This is the most direct chart on the page: it is your ownership, measured.
Dilution against what it bought
Has AXON's revenue per share grown faster than its share count?
Change since 2011. The gap between the lines is what each share gained or lost. Share counts are split-adjusted weighted averages.
Year
Share count, change since 2011
Revenue per share, change since 2011
2,011
0
0
2,012
-0.0793
0.3844
2,013
-0.0889
0.6804
2,014
-0.083
0.993
2,015
-0.0807
1.3911
2,016
-0.0993
2.3079
2,017
-0.0932
3.2112
2,018
-0.0255
3.7879
2,019
0.0098
4.8394
2,020
0.0395
6.2771
2,021
0.1137
7.6339
2,022
0.2204
9.8052
2,023
0.2695
12.6552
2,024
0.3217
16.5014
2,025
0.3859
21.2779
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · on the quarterly view, revenue per share is the trailing twelve months over that quarter's diluted count
→AXON issued 39% more shares from 2011 to 2025, but revenue per share still rose 2128%. The dilution bought more growth than it cost existing holders.
What this measures
The share count and revenue per share over the same years, both indexed to 100 at the start, so the two lines can be compared directly.
What good looks like. The per-share line above the share-count line: whatever the company did with its shares, more business ended up behind each one.
If it rises or falls. Issuing shares is not automatically bad. It is bad when the money raised buys less growth than the dilution cost, which is exactly what the gap between these two lines shows.
Why compare buybacks with stock compensation?
A company can trumpet billions in buybacks while quietly issuing nearly as much stock to employees. What matters to you is the net effect: is the share count actually falling? If not, the 'return' is mostly recycling.
→AXON is in a downtrend: the price is below the cloud where recent trading settled and that cloud is still falling. Both shorter readings point down as well, so nothing here disagrees with the downtrend.
How the trend above is worked out
The trend read is the daily Ichimoku picture, the same indicator drawn on the chart above. Five names, and what each one is: the TENKAN is the midpoint of the last 9 sessions' high and low, the fast line; the KIJUN is the same over 26 sessions, the slow one; the two SENKOU spans are midpoints drawn 26 sessions into the FUTURE, and the band between them is the KUMO cloud - because it is drawn forward, the support for the coming weeks is already fixed and a change of its direction can be seen coming; the CHIKOU is today's close compared with the close 26 sessions back. A trend confirms itself in that order and the checks follow it: price clears the cloud, holds above both lines, the Tenkan crosses above the Kijun, the cloud ahead turns up, and the Chikou stands higher than the price a month ago. Six of six therefore means all of that at once; a price sitting inside the cloud, or below its own lines, cannot get there. The last check is the one Ichimoku cannot answer - whether the S&P 500 did better over 12 months (252 sessions), measured on the SPY ETF with dividends included, on the same adjusted basis as the stock's own price. Our figures are the last close we hold, refreshed every trading night; the chart is live. None of this says anything about the business, and it is not advice.
Are AXON's insiders buying or selling shares with their own money?
Month
Buys ($)
Sells ($)
2023-11
0
11.2M
2023-12
0
6.2M
2024-01
0
8.9M
2024-02
0
0
2024-03
0
0
2024-04
0
0
2024-05
0
28.3M
2024-06
0
427,016
2024-07
0
0
2024-08
0
82.8M
2024-09
0
59.4M
2024-10
0
66.8M
2024-11
0
51.7M
2024-12
0
7.6M
2025-01
0
271,832
2025-02
0
0
2025-03
0
169,685
2025-04
0
5.4M
2025-05
0
21.4M
2025-06
0
5.3M
2025-07
0
0
2025-08
1.0M
28.8M
2025-09
0
11.9M
2025-10
0
7.1M
2025-11
0
7.4M
2025-12
0
21.1M
2026-01
0
6.2M
2026-02
0
6.6M
2026-03
0
28.2M
2026-04
0
0
2026-05
0
800,000
2026-06
0
26.2M
2026-07
0
6.4M
2026-08
0
21.1M
2026-09
0
5.6M
2026-10
0
0
→Since November 2023, insiders bought $1M and sold $533M on the open market, a net sale of $532M. A further 150 transactions were grants, option exercises or tax withholding, which say nothing either way.
What this measures
Open-market buys and sells by the company's own officers and directors, from their Form 4 filings. Grants, option exercises and shares withheld for tax are excluded, because they are compensation rather than decisions.
What good looks like. Buying with their own money, which is the one insider action that is hard to explain away.
If it rises or falls. Selling is weak evidence: insiders sell to diversify, to buy houses, and on pre-scheduled plans set months ahead. Buying is stronger evidence, because there is only one reason to do it. The absence of any buying over a long stretch is itself worth noticing.
The record
Who did what, exactly?
Date
Insider
Role
Type
Shares
Price
Value
2026-10-01
Cameron Brooks
CHIEF REVENUE OFFICER
tax
5,850
$422.21
$2.47M
2026-09-11
Isaiah Fields
Chief Legal Officer
SELL
1,017
$480.45
$488,618
2026-09-08
Patrick W Smith
CHIEF EXECUTIVE OFFICER
SELL
71
$501.99
$35,641
2026-09-08
Patrick W Smith
CHIEF EXECUTIVE OFFICER
SELL
410
$503.74
$206,532
2026-09-08
Patrick W Smith
CHIEF EXECUTIVE OFFICER
SELL
1,104
$505.59
$558,174
2026-09-08
Patrick W Smith
CHIEF EXECUTIVE OFFICER
SELL
744
$506.48
$376,820
2026-09-08
Patrick W Smith
CHIEF EXECUTIVE OFFICER
SELL
749
$507.48
$380,100
2026-09-08
Patrick W Smith
CHIEF EXECUTIVE OFFICER
SELL
1,774
$508.45
$901,991
2026-09-08
Patrick W Smith
CHIEF EXECUTIVE OFFICER
SELL
1,319
$509.32
$671,792
2026-09-08
Patrick W Smith
CHIEF EXECUTIVE OFFICER
SELL
1,348
$510.59
$688,271
2026-09-08
Patrick W Smith
CHIEF EXECUTIVE OFFICER
SELL
1,251
$511.43
$639,804
2026-09-08
Patrick W Smith
CHIEF EXECUTIVE OFFICER
SELL
1,033
$512.70
$529,621
2026-09-08
Patrick W Smith
CHIEF EXECUTIVE OFFICER
SELL
197
$513.38
$101,136
2026-08-31
Jennifer H Mak
Chief Accounting Officer
tax
156
$566.56
$88,199
2026-08-31
Cameron Brooks
CHIEF REVENUE OFFICER
tax
735
$566.56
$416,320
2026-08-31
Elizabeth Reid Coughlin
Chief Human Officer
tax
479
$566.56
$271,534
2026-08-31
Isaiah Fields
Chief Legal Officer
tax
763
$566.56
$432,375
2026-08-31
Joshua Isner
PRESIDENT
SELL
347
$561.08
$194,694
2026-08-31
Joshua Isner
PRESIDENT
SELL
373
$562.27
$209,726
2026-08-31
Joshua Isner
PRESIDENT
SELL
359
$563.50
$202,296
2026-08-31
Joshua Isner
PRESIDENT
SELL
1,232
$564.47
$695,430
2026-08-31
Joshua Isner
PRESIDENT
SELL
661
$565.37
$373,709
2026-08-31
Joshua Isner
PRESIDENT
SELL
188
$566.32
$106,468
2026-08-31
Joshua Isner
PRESIDENT
SELL
193
$567.53
$109,533
2026-08-31
Joshua Isner
PRESIDENT
SELL
1,684
$568.95
$958,114
2026-08-31
Joshua Isner
PRESIDENT
SELL
898
$569.70
$511,590
2026-08-31
Joshua Isner
PRESIDENT
SELL
643
$570.94
$367,114
2026-08-31
Joshua Isner
PRESIDENT
SELL
677
$571.98
$387,232
2026-08-31
Joshua Isner
PRESIDENT
SELL
314
$573.37
$180,037
2026-08-31
Joshua Isner
PRESIDENT
SELL
283
$574.67
$162,632
2026-08-31
Joshua Isner
PRESIDENT
SELL
1,108
$575.79
$637,973
2026-08-31
Joshua Isner
PRESIDENT
SELL
1,075
$576.80
$620,065
2026-08-31
Joshua Isner
PRESIDENT
SELL
625
$577.74
$361,089
2026-08-31
Joshua Isner
PRESIDENT
SELL
1,379
$578.73
$798,074
2026-08-31
Joshua Isner
PRESIDENT
SELL
1,663
$579.76
$964,146
2026-08-31
Joshua Isner
PRESIDENT
SELL
793
$580.59
$460,406
2026-08-31
Joshua Isner
PRESIDENT
SELL
318
$581.76
$184,999
2026-08-31
Joshua Isner
PRESIDENT
SELL
120
$582.84
$69,941
2026-08-31
Joshua Isner
PRESIDENT
SELL
477
$584.54
$278,826
2026-08-31
Joshua Isner
PRESIDENT
SELL
565
$585.72
$330,932
2026-08-31
Joshua Isner
PRESIDENT
SELL
280
$586.43
$164,201
2026-08-31
Joshua Isner
PRESIDENT
SELL
280
$588.46
$164,770
2026-08-31
Joshua Isner
PRESIDENT
SELL
109
$590.21
$64,333
2026-08-31
Joshua Isner
PRESIDENT
SELL
91
$592.51
$53,918
2026-08-31
Joshua Isner
PRESIDENT
SELL
40
$595.17
$23,807
2026-08-21
Jeffrey C Kunins
CPO & CTO
SELL
40
$605.77
$24,231
2026-08-21
Jeffrey C Kunins
CPO & CTO
SELL
80
$607.89
$48,631
2026-08-21
Jeffrey C Kunins
CPO & CTO
SELL
160
$609.56
$97,529
2026-08-21
Jeffrey C Kunins
CPO & CTO
SELL
141
$610.13
$86,029
2026-08-21
Jeffrey C Kunins
CPO & CTO
SELL
139
$611.50
$84,999
2026-08-21
Jeffrey C Kunins
CPO & CTO
SELL
200
$612.78
$122,556
2026-08-21
Jeffrey C Kunins
CPO & CTO
SELL
240
$613.65
$147,275
2026-08-21
Jeffrey C Kunins
CPO & CTO
SELL
80
$614.72
$49,178
2026-08-21
Jeffrey C Kunins
CPO & CTO
SELL
280
$616.32
$172,569
2026-08-21
Jeffrey C Kunins
CPO & CTO
SELL
400
$617.57
$247,027
2026-08-21
Jeffrey C Kunins
CPO & CTO
SELL
120
$618.27
$74,193
2026-08-21
Jeffrey C Kunins
CPO & CTO
SELL
80
$619.42
$49,553
2026-08-21
Jeffrey C Kunins
CPO & CTO
SELL
80
$620.79
$49,663
2026-08-21
Jeffrey C Kunins
CPO & CTO
SELL
40
$622.07
$24,883
2026-08-21
Jeffrey C Kunins
CPO & CTO
SELL
1,074
$623.84
$670,002
Why do the transaction types matter so much?
Most insider filings are not trades: stock grants, option exercises and tax withholding are how executives get paid, and gifts are estate planning. The signal lives in open-market transactions - a buy means an insider chose to spend their own cash on the stock. Sells are murkier: many are pre-scheduled 10b5-1 plans set months in advance. That's why the chart counts only open-market activity, and the table labels every row.
VIII
Ownership
informational
89.1%on Form 13F, 30 June 2026
5.1%officers, directors, founders
46.6%together
Top holders
Who owns Axon stock?
Fund managers filing Form 13F held 89.1% of the company's shares on 30 June 2026. The largest holder is BlackRock, Inc., with 10.3%. Insiders hold 5.1%.
#
Holder
Stake
Shares
Value
Change
1
BlackRock, Inc.Fund manager
10.26%
8.3M
$3.3B
+4.3%
2
Vanguard Capital Management LLCFund manager
6.32%
5.1M
$2.0B
+1.7%
3
State Street CorpFund manager
4.78%
3.9M
$1.5B
+5.5%
4
Vanguard Portfolio Management LLCFund manager
4.54%
3.7M
$1.4B
+2.2%
5
Invesco Ltd.Fund manager
3.97%
3.2M
$1.3B
+161.6%
6
Patrick W SmithCHIEF EXECUTIVE OFFICER · Form 4, 8 September 2026
3.84%
3.1M
$1.2B
-
7
Baillie Gifford & CoFund manager
3.77%
3.1M
$1.2B
+24.4%
8
FMR LLCFund manager
3.72%
3.0M
$1.2B
+26.2%
9
Geode Capital Management, LLCFund manager
2.85%
2.3M
$903M
+2.5%
10
Wellington Management Group LLPFund manager
2.59%
2.1M
$821M
-13.0%
11
Price T Rowe Associates IncFund manager
2.30%
1.9M
$731M
+137.3%
12
Westfield Capital Management Co LPFund manager
1.84%
1.5M
$582M
+40.2%
13
Sands Capital Management, LLCFund manager
1.82%
1.5M
$578M
-5.3%
14
Edgewood Management LLCFund manager
1.38%
1.1M
$439M
-44.5%
15
Morgan StanleyFund manager
1.34%
1.1M
$425M
+11.0%
16
Massachusetts Financial Services CoFund manager
1.26%
1.0M
$398M
+0.5%
17
Norges BankFund manager
1.15%
931,827
$364M
New
18
UBS Group AGFund manager
1.14%
927,111
$362M
+3.3%
19
Goldman Sachs Group IncFund manager
1.02%
825,444
$322M
+75.0%
20
Northern Trust CorpFund manager
0.95%
774,281
$302M
+1.2%
The full list of top holders is free with an account
Source: SEC Form 13F filings for the quarter to 30 June 2026, Schedules 13D and 13G, and Form 4. Shares on today's basis, value at the latest price.
Where does this list come from?
Fund managers with more than $100 million in US stocks report their holdings every quarter on Form 13F, up to 45 days after the quarter ends, so the fund figures are as of the last quarter end. A fund family reports as one manager, and funds together can report more than 100%: shares lent to short sellers are bought again by other funds, and both report them. Anyone holding more than 5% of a class files a Schedule 13D or 13G, and officers and directors report what they hold on Form 4 after every trade, so those rows carry their own dates. Short positions are not reported anywhere. A stake is the holder's shares as a share of all the company's shares, with other share classes converted at their market value.